Early stress drinking changes the brain, affects decisions, and increases risk of cognitive decline later in life.

A non-intoxicating compound in cannabis could offer a breakthrough treatment for alcohol use disorder. New research shows CBD ...

GLP-1 JABS may be able to ease symptoms of anxiety and depression by 40 per cent, a new study suggests. The blockbuster jabs ...

Researchers used positron emission tomography, or PET, brain imaging on 32 people with AUD and 29 controls. They found 11% lower synaptic density in the frontal cortex, striatum, and hippocampus of ...

It's well known that alcohol consumption is an age-old method for coping with stress. But recent research led by the University of Massachusetts Amherst has found that when such self-medication begins ...

New reports suggest GLP-1 medications like Ozempic may be altering not just appetite—but also how people experience alcohol, from mood changes to stronger hangovers.

Alcohol use disorder (AUD) remains a major public health challenge in the United States, contributing to more than 170,000 ...

This article explores the intersection between drinking and nutrition to reveal how alcohol-induced malnutrition can perpetuate a cycle of craving and relapse.

As wellness conversations broaden beyond abstinence, new research explores cannabis through a harm-reduction lens and what it could mean for moderating alcohol consumption.

The authors of the study say that it can help in understanding how alcohol rewires the brain's circuitry and suggest new approaches for helping people adapt to the long-term effects of alcohol use.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, drinking and opioid use disorders and addiction.

For the longest time, I was using eating as an activity,” the 29-year-old Texan told The Post. “We don’t have mountains or an ocean here in Dallas. We just love to shop, eat and drink.” So two years ...